Long-acting, high-potency, and high-dose opioids were associated with an increased risk for invasive pneumococcal disease.
Invasive mechanical ventilation in patients with severe community-acquired pneumonia appeared to increase their mortality risk.
Nasopharyngeal samples collected from young children with acute otitis media were analyzed for S pneumoniae, H influenzae, and Moraxella catarrhalis and compared before and after PCV13 introduction.
Patient, practice, and provider characteristics are associated with inappropriate antimicrobial prescribing in the outpatient setting.
The FDA approved the supplemental New Drug Application for Avycaz to treat adults with hospital-acquired or ventilator-associated bacterial pneumonia.
The preoperative physiotherapy intervention cut the incidence of postoperative pulmonary complications by 50%.
Procalcitonin may decrease mortality rates in patients with acute respiratory infections, including pneumonia.
Short-term incidence of leukemia, lymphoma, and brain cancer may be higher in children who were hospitalized with pneumonia.
Mortality from severe pneumonia may be significantly reduced with corticosteroids.
Non-ventilator hospital-acquired pneumonia is a significant burden in US acute care hospitals and poses a risk to nonelderly, non-intensive unit patients.
AuroMedics Pharma announced a voluntary recall of 1 lot of Linezolid injection after a batch found contained mold.
Researchers identified 4 specific symptoms that could be the basis for a pneumonia diagnosis.
Educational campaigns regarding the value of vaccines should integrate social psychological considerations with health communication principles.
The ability of machine learning programs to diagnose medical conditions and predict outcomes is discussed in an opinion article.
No single finding appears to reliably predict a pneumonia diagnosis in pediatric patients younger than 5 years of age.
The 2006 CHEST management algorithms for acute, subacute, and chronic cough appear to be useful in treating adults globally.
Prophylactic antibiotics administered to patients who were mechanically ventilated reduced the rate of ventilator-associated pneumonia.
In contrast to previous study findings, inhaled corticosteroids do not appear to increase risk for pneumonia in patients with COPD with moderate airflow limitation.
Strictly following empirical antimicrobial treatment guidelines in patients with hospital-acquired or ventilator-associated pneumonia may result in overtreatment with antibiotics.
Study results indicate that delafloxacin has potent in-vitro activity against most common pathogens seen in community-acquired pneumonia.
Combination antibiotic therapy with a macrolide improves hospital length of stay in patients with severe community-acquired pneumonia.
Researchers developed a clinical tool to predict prolonged hospital stays in patients with pediatric community-acquired complicated pneumonia.
Investigators found that macrolides correlated with lower odds of treatment failure in patients younger than 5 with CAP.
Low education and low income are linked to lower uptakes of PCV13 in minorities 65 years and older.
Using serum procalcitonin levels to diagnose and manage bacterial pneumonia decreases length of hospital stay.
Fewer than half of patients with asthma have received a pneumococcal vaccination.
While the newest high-valent PCV10 and PCV13 vaccines are effective in preventing IPD caused by the serotypes within the vaccines, breakthrough patterns of conversion to non-PCV13 serotypes are emerging.
Early time to positivity of blood culture in patients with bacteremic pneumococcal pneumonia predicted the risk for invasive mechanical ventilation.
Gastroesophageal reflux disease (GERD) is associated with long-term risk of pneumonia, especially in the younger population and in patients who have been treated with proton pump inhibitors.
Three cases of community-acquired pneumonia were reported in otherwise healthy adults.